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Abstract
Objective: To explore the relationship between the integration of mitochondrial DNA(mtDNA)
in the nuclei of cervical epithelium cells and the expression of c-myc.
Methods: The expression of c-myc protein was measured by immunohistochemical test in 40
cases of the uterine cervix cancer, 30 cases of cervical intraepithelial neoplasia (CIN) and 30 cases
of normal cervical epithelium; the sequence of mtDNA in the nuclei was detected by in situ
hybridization technique.
Results: The detection rates of mtDNA in the nuclei of cervical epithelium cells were 27.5%, 13.3%
and 0% in cervical carcinoma, CIN, and normal cervical epithelium respectively. The expression
rate of c-myc in cervical mucoma cells was 67% in the mtDNA sequence positive group and was
significantly higher than that in the negative group (36%).
Conclusion: The integration of mtDNA into the nuclei of cervical epithelium cells may be involved
in the carcinogenesis of cervical epithelium cells and the expression of c-myc might be related to
the integration of mtDNA sequence into nuclei of cervical epithelium cells.
Background
In recent years, several studies have found that point
mutation of some tumors was relevant to that of mtDNA,
but it is unclear for causal relation, which could not rule
out the possibility of mtDNA integration to the nuclear
genome and inducing carcinogenesis. Actually there were
objective conditions for the intranuclear transfusion and
integration of mtDNA and its fragments. Physical, chemi-
cal and certain biological factors may cause mtDNA muta-
tions, the collapse of mitochondrial membrane, and give
rise to mtDNA and its fragments dissociation into the
cytoplasm. When the free mtDNA and its fragments in the
cytoplasm generate excessivelly and the activity of
DNAase DNAase-like materials is degraded, the free
mtDNA or its fragments probably has the similar effect of
tumorgenic virus, passing through nucleopore and ran-
domly integrating into genome DNA. The roles of mtDNA
intranuclear integration could be as follows: (1) The inte-
gration fragments or integration sites do not influence the
normal function of genome and have little impact on the
biological characteristics of the host cells; (2) activation of
a "healthy gene" enhances the body's disease resistance
and promotes biological evolution; (3) oncogene activa-
tion or anti-oncogene inhibition causes cell proliferation
and differentiation out of control, which finally leads to
cancerization; (4) apoptosis gene activation or anti-apop-
tosis gene inhibition induces cells apoptosis rapidly. More
and more data indicated that mtDNA integration existed
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in the nuclear genome of tumor cells. Liang etc. [1] has
also found the phenomenon of mtDNA fragments intra-
nuclear integration in early glioma cells by fluorescent in
situ hybridization of chromosomes. Kamimura etc. [2]
detected a section of mtDNA sequence homology in the
nDNA of tumor cells, which is composted of three uncon-
secutive sections of mtDNA: 12S rRNA, cytochrome oxi-
dase I (COX-I) and a part of ND4L/ND4 DNA. Later Shay
[3] has got the similar findings in the nuclear genome
research on Hela TG cervical cancer cells. mtDNA intranu-
clear integration may lead to the instability of chromo-
some DNA and oncogene activation and/or anti-
oncogene deactivation, which lead to abnormal cell pro-
liferation and differentiation and finally result in canceri-
zation.
Carcinoma of the uterine cervix is the second commonest
malignancy in women only next to breast cancer. Activa-
tion of oncogene and inactivation of anti-oncogene are
molecular basis of cancerization of cells. Some scholars
[4] suggested that mtDNA, the unique genetic materal
outside of chromosome, may be randomly integrated into
genome DNA and activate oncogene or inactivate anti-
oncogene, and finally induce the development of tumor.
Previous study of our lab [5] has found that higher fre-
quency of mtDNA mutation existed in cervical cancer. The
purpose of this study was to enrich the study of molecular
mechanism of cervical cancer by detecting intra-nucleus
integration of mtDNA segment in cervical mucosa cells
and exploring its correlation with c-myc (an important
oncogene).
Materials and methods
Cases
40 patients with cervical cancer were collected from 2000
to 2004 for biopsy samples, including 34 cases of squa-
mous cell carcinoma and 6 cases of adenocarcinoma.
According to FIGO clinical staging standard, 13 cases were
in stage I and 27 cases were in stage II; These cases were
classified as histological grading standard: 9 cases in grade
I, 21 cases in grade II and 11 cases in grade III. radical hys-
terectomy plus pelvic curettage of lymph node was per-
formed for all these patients whose age ranged from 36 to
71 years old, and median age was 59.5 years old. 30 cases
of CIN and 30 cases of normal cervical epithelia were
taken as control. Patients were informed of the nature,
goals, potential benefits, and risks of participating in the
study and signed a written consent form approved by the
Institutional Ethics Committee.
Pathological section and staining
Tissues of cervical cancer were taken, fixed with10% for-
maldehyde and embedded with paraffin, HE staining or
IHC were used for sections. Some tissues were taken for 5
μm frozen sections, fixed with 4% paraformaldehyde for
hybridization in-situ.
DNA hybridization in-situ
mtDNA probe sequence refered to the relative literature
[6]. Probe marks adopted Roche random primer digoxin
marks and reagent kits, according to the manufacture's
instruction. 2 μg of restriction endonuclease HaeIII (GG ↓
CC) and HpaII (C ↓ CGG) were respectively added to 1 μg
of mtDNA probe in 37°C water bath for 2 h for enzymatic
digestion which was prepared for hybridization.) Dilu-
tion of the probe was 1.5 ng/μl. The hybridization solu-
tion contained: 50% deionized formamide, 0.1%N
Lauroylsarcosine,0.02% SDS, 2% blocking reagent and 5
× SSC. Hybridization solution without probe was used as
negative control. The steps of the hybridization in situ
were as follows: (1) each section was initially treated with
0.01 mol/l HCL and proteinase K at 37°C for 30 min,
then washed with 0.1 mol/L glycine for 5 min and fixed
with 4% paraformaldehyde for 5 min; (2) Prehybridiza-
tion: 30 μl prehybridization solution was added to each
section, at 37°C for 30 min; (3) Hybridization: 30 μl
hybridization solution with probe was added to each sec-
tion at 37°C for 16 h; (4) 30 μl digoxin antibody labeled
with alkaline phosphoric enzyme was added at 42°C for
0.5 h; (5) coloration: the section was colored by NBT/
BCIP for 30~60 min for microscopic examination and
photograph. If the nucleus had hyacinthine staining but
the intercellular substance and control hadn't such stain-
ing, it was regarded as positive expression.
Detection of the c-myc expression by 
immunohistochemical test
Immunohistochemical reagent c-myc monoclonal anti-
body produced by U.S. Symed (purchased from Beijing
Zhongshan Biological Technology Company, China).
Operating steps: (1) the section was dewaxed and then put
into water. (2) repaired for 20 min by hot platform. (3)
The normal horse serum was added to section for 20 min
at 1:50 dulitions for blocking) (4) the section was incu-
bated with monoclonal antibody at 1:60 dulitions at 4°C
overnight; (5) 1:120 double (secondary) antibody was
added at room temperature for 60 min (6) SAHRP 1:150
for 60 min at room temperature. (7) DAB staining. (8)
Hematein double staining, dehydration, transparent
mount. The standard of c-myc positive reaction: the reac-
tion product of c-myc positive reaction was brown parti-
cles, distributed in cell nucleus, it was regarded as positive
expression if the percentage of possive cells was more than
30% under 10 high power fields.
Statistical methods
The statistical analysis was performed by using SAS
(6.12_version)) statistical software. The statistical com-Journal of Experimental & Clinical Cancer Research 2008, 27:36 http://www.jeccr.com/content/27/1/36
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parisons between groups were performed by χ2 test, P <
0.05 was considered statistically significant.
Results
Intranucleus integration of mtDNA sequence
mtDNA sequence was detected in 15 cases of cervical
mucosa nucleus by hybridization in-situ (see Fig 1). Inte-
gration rates in normal cervix, CIN and cervical cancer
were 0%, 13.3% and 27.5% respectively. Difference
among the three groups was significant (χ2 = 9.054, P <
0.05, see Table 1).
C-myc oncogene expression
Positive expression was diffused in cervical squamous cell
cancer but mesenchymal was negative (see Fig 2). In CIN,
positive expression was seen in atypical proliferation of
epithelium whereas normal epithelia and mesenchyma
were negative. The expression rates of C-myc in normal
cervix, CIN and cervical cancer were 7%, 33% and 73%
respectively. Difference among the three groups was sig-
nificant (χ2 = 10.658, χ2 = 27.503, P < 0.05, Table 2).
Relationship between intranuleus integration of mtDNA 
sequence and C-myc oncogene expression
In 100 samples, 41 were c-myc positive, of which 10 cases
were positive of mtDNA hybridization in-situ nucleus
staining; 59 cases were c-myc negative, of which 5 cases
were positive of mtDNA hybridization in-situ nucleus
staining. Difference was significant (χ2 = 4.81, P < 0.05)
(Table 3)
Discussion
Proper insertion of mitochondria gene into nucleus
genome is important in biological evolution, but
improper insertion may be one of the main causes of cer-
tain genetic diseases, malformation or tumors. Hu Yide et
al [7] adopted gene transfer technology to transfect
mtDNA fragment to mouse NIH3T3, which induced cells
malignant transformation. It suggested that mtDNA inte-
gration in nucleus was an important factor to promote
cells cancerization. Ling Xianlong et al [8] also found
intranucleus integration of mtDNA fragment in cell
nucleus of gastric cancer. Shay et al [9] found CoIII of
mtDNA in Hela TG cells arranged in c-myc gene. The
resulting mRNA contained not only genetic information
Integration of mtDNA in the nuclei of cervical epithelium  cells detected by in situ hybridization The nucleus had hya- cinthine staining but the intercellular substance and control  hadn't such staining, it was regarded as positive expression Figure 1
Integration of mtDNA in the nuclei of cervical epithelium 
cells detected by in situ hybridization The nucleus had hya-
cinthine staining but the intercellular substance and control 
hadn't such staining, it was regarded as positive expression. 
(A: normal cervix tissure; B: CIN tissure; C: cervical cancer 
tissure)
  $ 
% 
  & 
Table 1: Integration of mtDNA in nuclei of cervical epithelium 
cells
Groups n + - integration 
rate (%)
p value
Cervical 
carcinoma
40 17 23 42.50% χ2 = 9.054(P < 0.05)
CIN 30 4 26 13.30% χ2 = 9.054(P < 0.05)
Normal cervix 30 0 30 0%Journal of Experimental & Clinical Cancer Research 2008, 27:36 http://www.jeccr.com/content/27/1/36
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from c-myc, but also from CoIII. Our lab had similar find-
ings in FISH of Hela cells of cervical cancer cultured in
vitro.
C-myc oncogene was located in chromosome 8q24, total
length 6~7 kb. It had 3 exon, coding protein consists of 49
amino acid residues, molecular weight reaches 64/67
kDa. C-myc over-expression and proliferation was often
found in cervical cancer tissue. Ngan [10] adopted immu-
nohistochemical technology to study 45 cases of normal
cervical tissue, 38 cases of stage I CIN, 37 cases of stage II
CIN and 43 cases of stage III CIN: The results showed that
c-myc expression was active in poorly developed cells. It
suggested that in CIN evolution, c-myc was an important
proto-oncogene. Aoyama [11] tested various pathological
cervical tissues with PCR. He found that c-myc oncogene
was easily proliferated and (or) over-expressed. Present
study first used IHC technology to explore c-myc expres-
sion in cervical tissues. Data showed that c-myc expres-
sion decreases gradually in cervical cancer, CIN and
normal cervical tissue. With the increase of malignancy,
positive expression became stronger, low differentiation
squamous cell cancer was stronger than high differentia-
tion one and grade III CIN was stronger than grade I CIN,
which basically conformed to the reports in literature [1].
In order to exploring the correlation between c-myc onco-
gene expression and mtDNA integration into genome,
DNA hybridization in-situ on frozen sections was also
used in present study. The results showed that in the
course of chronic cervical inflammation →CIN →cervical
cancer, detection rate of mtDNA sequence arranged in
DNA genome increased in turn, which suggested its rela-
tion with the development of cervical cancer. C-myc gene
expression rates of cervical mucosa cells were 67% in
mtDNA detection group and 36% in non-detection group
respectively. Thus, We infered that acted by certain physi-
cal, chemical and biological factors, mtDNA mutation
took place. Mutation in D-LOOP may change affinity of
trans factors related to mitochondria DNA and replica-
tion, copy number of mtDNA therefore increases obvi-
ously, normal metabolic balance was damaged, free
mtDNA and its fragments were excessive and activity of
nucleic acid catabolic enzymes in cells decreases mean-
The expression of c-myc in cervical epithelium cells detected  by immunohistochemical test Figure 2
The expression of c-myc in cervical epithelium cells 
detected by immunohistochemical test. The standard 
of c-myc positive reaction: the reaction product of c-myc 
positive reaction was brown particles, distributed in cell 
nucleus, it was regarded as positive expression if the per-
centage of possive cells was more than 30% under 10 high 
power fields. (A: normal cervix tissure; B: CIN tissure; C: 
cervical cancer tissure).
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Table 2: The expression of c-myc in cervical epithelium cells
Groups n positive negative positive 
rate (%)
p value
Cervical 
carcinoma
40 29 11 73% χ2 = 10.658(P < 0.05)
χ2 = 27.503(P < 0.05)
CIN 30 10 20 33% χ2 = 10.658(P < 0.05)
Normal 
cervix
30 2 28 7% χ2 = 27.503(P < 0.05)Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Experimental & Clinical Cancer Research 2008, 27:36 http://www.jeccr.com/content/27/1/36
Page 5 of 5
(page number not for citation purposes)
time, mtDNA and its fragments were free outside mito-
chondria, it had similar effect of cancerous virus, arranged
randomly into nucleus genome and activated oncogene or
inhibited anti-oncogene, which influenced cell prolifera-
tion and differentiation and developed tumor.
Research already found that nucleus DNA and mtDNA
might wander in cells [12]. Mitochondria RNA can be
reversely transcripted into mtDNA in cytoplasm, there is
nucleopore on membrane and DNA ligase in nucleus. So
integration of mtDNA in nucleus gene may induce cancer-
ation of cells, change of mitochondria structure and quan-
tity increase. Advanced study was needed to confirm the
hypothesis above.
Present study detected intranucleus integration of mtDNA
fragment in cervical mucosa cells, and analyzed the corre-
lation between mtDNA fragment integration and c-myc
expression. In conclusion, We tentatively assumed that
Integration of mtDNA into nuclei of cervical epithelium
cells may be involved in the carcinogenesis of cervical epi-
thelium cells and expression of c-myc gene might be
related to integration) of mtDNA sequence into nuclei of
cervical epithelium cells. It provided new clues to reveal
molecular mechanism of cervical cancer.
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